There is now no doubt that ketone bodies (acetoacetate and D-3-hydroxybutyrate) are important oxidizable substrates for peripheral tissues, especially the brain. Although oxidation is the major fate of ketone bodies, more recent evidence suggests that ketone bodies can act as lipogenic substrates in certain tissues, notably the developing brain and the lactating mammary gland. Apart from their roles as respiratory fuels or lipogenic substrates, it is now clear that the concentrations of ketone bodies in the circulation can act as 'signals' to control their own formation (via effects on adipose-tissue lipolysis) and t o regulate the supply of glucose precursors (glycerol, alanine and lactate).
fed rats when both were presented with the same concentration of long-chain fatty acid. A more detailed investigation of the time course of the changes in ketogenesis from exogenous oleate in perfused livers indicated that the major increase occurred 5-10h after withdrawal of food and that this correlated with the depletion of hepatic glycogen and the switch-on of gluconeogenesis (McGarry et a / . , 1973).
(b) Sit(. of'uegulution. Long-chain fatty acids taken up by liver are either esterified to form triacylglycerol (for subsequent release as very-low-density lipoproteins) and phospholipids, or they are partially oxidized within the mitochondrion to acetyl-CoA (Scheme I). The acetyl-CoA can then either enter the tricarboxylic acid cycle for complete oxidation or be converted into acetoacetate via the hydroxymethylglutaryl-CoA pathway. Either of these two branch points in long-chain fatty acid metabolism are potential candidates for the primary regulation of ketogenesis. Until recently much emphasis was placed on the role of citrate synthase in the regulation of ketone-body synthesis (see Newsholme & Start, 1973) , and indeed many elegant studies with isolated mitochondria indicate that control is exerted at this step. However, studies with perfused liver or isolated hepatocytes have shown that the primary site of intrahepatic regulation is at the level of disposal of long-chain acyl-CoA (Scheme 1).
Part of the evidence is that in a number of different situations changes in the rate of ketogenesis are accompanied by reciprocal alterations in the rate of esterification when long-chain fatty acids (oleate or palmitate) are the exogenous substrates (Mayes & Felts, 1967; McCarry & Foster, 1971 ; Ontko, 1972; Whitelaw & Williamson, 1977; Benito &Williamson, 1978; Benito et al., 1979) . However, for medium-or short-chain fatty acids (octanoate or butyrate), which d o not form triacylglycerols and d o not require the carnitine acyltransferase system to enter the mitochondrial matrix (Scheme I), the differences in rates of ketogenesis are considerably less than for the long-chain fatty acids. This latter point is further support for the view that the disposal ofacetyl-CoA between the tricarboxylic acid cycle and the hydroxymethylglutaryl-CoA pathway is of secondary importance in regulatory terms in the intact hepatocyte.
The disposal of long-chain acyl-CoA between the esterification and /%oxidation pathways could theoretically be regulated in the short term in a number of ways, including alteration of enzyme activity by allosteric effectors, by substrate and cofactor availability or by an interconversion cycle (phosphorylation-dephosphorylation). Since regulation is occurring at a branch point, either it can be applied on one of the two divergent pathways, allowing the other to remove the available substrate, or it can affect the activity of both in a reciprocal manner. Present evidence suggests that the major site of regulation is the transfer of long-chain acyl-CoA into the mitochondria for 8-oxidation. The transfer mechanism involves the sequential actions of carnitine acyltransferase I (EC 2.3.1.21) on the outer side of the mitochondrial inner membrane and carnitine acyltransferase I 1 on the inner side of the membrane (Kopec & Fritz, 1973) . Inhibition of this system with (+)-acylcarnitine results in diversion of long-chain acyl-CoA to the esterification pathway, suggesting no defect in the capacity of the latter (McGarry et d., 1973) . The changes in rates of ketogenesis with (-)-octanoylcarnitine, which, unlike octanoate, requires carnitine acyltransferase II for its entry into the 8-oxidation pathway, parallel those of a long-chain fatty acid rather than those of octanoate (McCarry & Foster, 1974) . If it is accepted that the carnitine acyltransferase system is the major site for the regulation of hepatic fatty oxidation and hence of ketogenesis, the question arises as to how it is controlled and how the control is linked to the carbohydrate status of the liver.
(c) The intracelliclur signal. It would seem a prerequisite that any effector of the carnitine acyltransferase system should be a metabolite whose concentration would change rapidly with alterations of metabolic flux and that it should signal the carbohydrate status of the liver.
Carnitine is a co-substrate for the transferase system and its availability can affect the entry of long-chain acyl-CoA into the mitochondria. The hepatic concentration of carnitine in uiuo increases in starved rats and in other situations in which treatment of the rat results in increased rates of ketogenesis in oitro (McGarry et al., 1975 Whitelaw & Williamson, 1977) from fed rats increases the rate of ketogenesis, but only to about 50 %of that observed in livers from starved rats. However, administration of carnitine to fed rats to achieve hepatic concentrations seen in starvation did not alter the concentration of ketone bodies in the blood (Brass & Hoppel, 19786) , and it has recently been suggested that the apparent increase in hepatic carnitine in starvation can be accounted for by the decrease in liver mass secondary to the depletion of glycogen and water (Brass & Hoppel, 1978~) . Thus, although there is n o doubt that the availability of carnitine has a stimulatory influence on the rate of ketogenesis, it does not appear t o be the signal responsible for the short-term regulation of this process. On reflection this conclusion is not surprising, because the hepatic carnitine concentration is not linked in any way to the carbohydrate status of the liver, nor have there been any studies which show rapid changes in its concentration. It should be borne in mind that the free carnitine released on reaction of carnitine acyltransferase I1 with long-chain acylcarnitine must be transported back to the cytosol. This process is facilitated by a carnitine/acylcarnitine exchange reaction (Ramsay & Tubbs, 1975; Pande, 1975) across the mitochondria1 inner membrane, and it is possible that the rate of this exchange could influence the entry of long-chain acyl-CoA into the mitochondria for oxidation.
With the criteria outlined at the beginning of this section in mind, McGarry and his colleagues tested the effects of a large number of metabolic intermediates on the activity of carnitine acyltransferase 1 and found that malonyl-CoA was a potent inhibitor of the enzyme . The concentration of malonyl-CoA is correlated in a number of situations with the rate of lipogenesis (Guynn et al., 1972; Cook et al., 1977; McGarry et al., 1978b) , which in turn is dependent on the supply of carbohydrate precursors (glycogen, glucose, lactate and pyruvate). Thus a high rate of lipogenesis and hence increased malonyl-CoA concentrations, as occurs in the carbohydrate-fed animal, will inhibit entry of long-chain acyl-CoA into the mitochondria and therefore depress ketogenesis (Scheme 2). Evidence in support of this concept is the existence of a reciprocal relationship between the rates of lipogenesis and ketogenesis, and between esterification and ketogenesis in isolated hepatocytes under various conditions (Benito &Williamson, 1978; Benitoetal., 1979) . It must beemphasized, however, that inhibition of lipogenesis in perfused liver or hepatocytes from fed rats by increased concentrations of non-esterified fatty acids (Mayes & Topping, 1974) , by specific inhibitors such as (-)-hydroxycitrate (Brunengraber & Lowenstein, 1976) or 5-(tetradecyloxy)-2-furoic acid (Benito & Williamson, 1978) , or by acute depletion of glycolytic intermediates (Williamson & Whitelaw, 1978a) , does not result in the rates of ketogenesis observed with hepatocytes from starved rats.
To summarize the present evidence with regard to the intracellular signal: carnitine has a stimulatory effect on ketogenesis by increasing the activity of carnitine acyltransferase I, but there are doubts as to its physiological role as a regulatory signal. In contrast, malonyl-CoA at concentrations within the physiological range inhibits carnitine acyltransferase I and thus provides an intrahepatic link between the metabolism of carbohydrate and fat (Scheme 2).
One point that is not yet resolved is whether carnitine acyltransferase 11 is involved in the regulation of long-chain fatty acid oxidation. It appears that malonyl-CoA specifically inhibits carnitine acyltransferase 1 (McCarry et al., 1978a ), yet experiments with (-)-octanoylcarnitine, which only requires carnitine acyltransferase 11 to enter the mitochondria, indicate that the activity of transferase II alters in a number of situations ) where there appears to be no change in the amount ofenzyme protein. It would therefore seem that the two transferases are regulated in a concerted way, but the mechanisms or effectors are different. A possible modulator of carnitine acyltransferase I1 activity is the mitochondrial-matrix concentration of free CoA required to re-form long-chain acyl-CoA (Scheme I). Alternatively, an intramitochondrial metabolite may act as an effector of carnitine acyltransferase 11. It is clear that further studies are required on the properties of the carnitine acyltransferase system.
( d ) Direct qfects oj'hormones. Hormones can influence the rate of lipolysis in adipose tissue and therefore alter the flux of non-esterified fatty acids to the liver. A key question i s whether in addition hormones have any short-term direct effects on ketogenesis in the liver. It is well established that glucagon or dibutyryl cyclic A M P stimulates ketogenesis from both endogenous substrates and from added long-chain fatty acids in livers or , 1978~) is the exogenous substrate, suggesting that the site of action of glucagon and other hormones acting via increases in cyclic AMP concentration is the disposition of longchain acyl-CoA between the pathways of esterification and /I-oxidation. Glucagon (or cyclic AMP) inhibits lipogenesis both in vivo (Cook etal., 1977) Harris, 1975) , and the postulated mechanisms involve decreased generation of pyruvate via inactivation of pyruvate kinase and inhibition of acetyl-CoA carboxylase (both enzymes appear to be regulated by a phosphorylation-dephosphorylation cycle). Recent experiments with isolated hepatocytes have shown that the stimulatory effect of glucagon on ketogenesis is accompanied by the expected decrease in malonyl-CoA concentrations, and it was concluded that the primary action of the hormone is on lipogenesis (McGarry et a/., 19786) . However, when hepatocytes from fed rats are incubated with oleate and 5-(tetradecyloxy)-2-furoic acid (an inhibitor of citrate efflux from the mitochondria and therefore of lipogenesis), VOl. 7 cyclic A M P still increases ketogenesis and decreases esterification, which suggests that glucagon may also act a t a site in the esterification pathway (Benito et a/., 1979) . In this connection, Heimberg and his colleagues have observed decreased esterification of fatty acids by microsomal fractions isolated from livers of fed rats perfused with dibutyryl cyclic A M P (Soler-Argilaga et a/., 1978) .
There are comparatively few unequivocal reports of effects of insulin on hepatic ketogenesis in uitro. Topping & Mayes (1972) observed that insulin decreased the oxidation of oleate and increased its esterification in isolated perfused livers of fed rats, and suggested that insulin lowered cyclic A M P concentration and thereby decreased hepatic lipolysis. An alternative explanation is that insulin stimulated lipogenesis and increased malonyl-CoA concentrations, which in turn decreased the entry of long-chain acyl-CoA into the j3-oxidation pathway. An interesting finding that deserves further study is the report that the activity of the mitochondrial glycerol phosphate acyltransferase is increased (about 25 %) when livers from fed rats are perfused with insulin (Bates eta/., 1977).
Vasopressin, a hormone that appears to act without altering cyclic A M P concentrations, inhibits ketogenesis from oleate in hepatocytes from fed rats (D. H. Williamson & V. Ilic, unpublished work) . The mechanism of this effect is at present unknown.
Ketone bodies as lipogenic precursors
Recent studies with 14C-labelled ketone bodies have reinforced the view that oxidation is the major fate of ketone bodies in peripheral tissues. However, in certain tissues a significant proportion of the label is found in the lipid fraction. Thus the spinal cord and brain of suckling rats (Cremer & Heath, 1974; Ramsey, 1976; Webber & Edmond, 1977) and the lactating mammary gland of the rat (Robinson &Williamson, 1978) are major sites of ketone-body incorporation into lipid, whereas adipose tissue in rats (Robinson & Williamson, 1978) or mice (Rous, 1977) is less important. In the rat foetus, brown adipose tissue shows the highest rate of incorporation of label into lipid, whereas the amount incorporated into brain lipid is low (Seccombe e t a / . , 1977) . These findings raise the question as to how the carbon of ketone bodies is converted into lipid.
The pathway of oxidation of ketone bodies involves formation of acetyl-CoA in the mitochondria by the 3-hydroxybutyrate dehydrogenase, 3-0x0 acid CoA-transferase and acetoacetyl-CoA thiolase reactions (Scheme 3). The acetyl-CoA condenses with oxaloacetate to form citrate, which can then either be metabolized further in the tricarboxylic acid cycle or be transferred to the cytosol via the tricarboxylate carrier on the inner membrane. In lipogenic tissues this citrate can be cleaved by ATP citrate lyase (EC 4.1.3.8) to provide acetyl-CoA for lipid or sterol synthesis.
(a) Acetoacetyl-CoA synfhcfase. The description by Stern (1971) of a cytosolic enzyme in rat liver, acetoacetyl-CoA synthetase, which converts acetoacetate into acetoacetylCoA in the presence of ATP and CoA, stimulated the search for this enzyme in other lipogenic tissues. Detectable activity has been found in the cytosol of developing rat brain (Buckley & Williamson, 1973) , adipose tissue (Buckley & Williamson, 1975; Rous, 1977) and lactating mammary gland (Buckley & Williamson, 1975; Robinson & Williamson, 1978) . The activity of the enzyme is sensitive to the nutritional state (decreases in starvation), and in all tissues and situations so far examined the activity correlates well with the rate of lipogenesis. The affinity of acetoacetate for the synthetase is high (K,,, less than 5 0 ,~~; Robinson , whereas the K , of the keto acid for the mitochondrial 3-0x0 acid CoA-transferase (EC 2.8.3.5) is nearly an order of magnitude higher (Tildon & Sevdalian, 1972) . It must be stressed, however, that acetoacetyl-CoA synthetase has not yet been purified from any tissue.
(b) The cytosolic pathway. The presence of an active acetoacetyl-CoA thiolase in t h e cytosol of all tissues containing acetoacetyl-CoA synthetase led to the postulate that acetyl-CoA can be formed directly from acetoacetate in this compartment (Scheme 3 ; Buckley & Williamson, 1973) . I n this way acetoacetate can act as a precursor of fatty acid without the need for citrate transport from the mitochondrial matrix. The potential advantages of this system are that less ATP is consumed per acetyl-CoA unit formed, and the high affinity of the cytosolic enzyme can direct acetoacetate to lipid synthesis when it is available at low concentrations (Scheme 3). There is some evidence for the operation of this cytosolic pathway in brain of suckling animals in uitro, where (-)-hydroxycitrate (an inhibitor of ATP citrate lyase) or inhibitors of mitochondrial citrate transport decrease the incorporation into lipid of ''C-labelled glucose and 3-hydroxybutyrate, but not the incorporation of acetoacetate or acetate (Patel & Owen, 1976) . Rat brain cytosol also contains 3-hydroxy-3-methylglutaryl-CoA synthase (EC 4.1.3.5) (Patel &Clark, 1978) , so that acetoacetate can act as a direct precursor for sterol synthesis in this compartment. l n addition, the acetoacetyl-CoA formed from acetoacetate can be converted in the cytosol into butyryl-CoA, which is the preferred primer for lipogenesis in a number of mammalian tissues (Lin & Kumar, 1972) . Further work is required t o delineate the relative importance of the mitochondrial and cytosolic pathways of acetoacetate utilization.
Regulation of substrate supply by ketone bodies
In addition to acting as oxidizable fuels and lipogenic precursors, ketone bodies can regulate the supply and metabolism of other substrates. In most of the examples at present known, the effects are brought about by the direct interactions of ketone-body metabolism on the pathway responsible for the production or utilization of the other substrate.
Ketone bodies decrease glucose utilization and/or the oxidation of pyruvate in heart, and the mechanism was established by Randle and co-workers (Randle et al., 1966) . Similar findings have been reported in a number of other peripheral tissues, including diaphragm, soleus muscle, lactating mammary gland, kidney and brain.
It is also well established that ketone bodies can inhibit adipose-tissue lipolysis, either directly (Bjorntorp, 1966) or indirectly via the stimulation of insulin secretion (Madison ef al., 1964) . The net result is a feedback mechanism to control ketone-body formation and the supply of glycerol, an important precursor of glucose synthesis.
A new development concerns the possible indirect regulation of hepatic gluconeogenesis by ketone bodies. Alanine derived from muscle is an important precursor of glucose and a means of transporting both carbon and nitrogen to the liver. Decreased plasma alanine concentrations accompany the hyperketonaemia of starvation, pregnancy, diabetes, trauma and ketotic hypoglycaemia (see Robinson & Williamson, 1979) . Infusion of 3-hydroxybutyrate into humans decreases plasma alanine concentration, and it is likely that the hypoalaninaemia is due to decreased muscle output of alanine (Sherwin et al., 1975) . Thus it appears that ketone bodies may indirectly influence gluconeogenesis by limiting the supply of alanine. Palaiologos & Felig (1976) have suggested that ketone bodies decrease alanine production by muscle via inhibition of glycolysis (Randle et a / . , 1966) and consequent limitation of pyruvate for transamination to alanine. Exogenous pyruvate in vitro is able to reverse the inhibitory effect of ketone bodies on alanine production (Palaiologos & Felig, 1976) . However, in prolonged starvation the carbon for alanine formation is derived mainly from sources other than glycolytically generated pyruvate (see Snell, 1979) . These sources are alanine in peptide chains or the carbon skeletons of other amino acids produced on breakdown of protein, which can then be converted into pyruvate. The fact that a decrease in nitrogen excretion accompanies the prolonged infusion of ketone bodies into starved humans (Sherwin et al., 1975) suggests that they may have a protein-sparing effect. This would make physiological sense, because when ketone bodies are available this is a signal for a decreased requirement for glucose. At present there is no unequivocal evidence that ketone bodies directly affect proteolysis, nor for interactions between ketone-body metabolism and the oxidation of amino acids derived from protein breakdown.
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